Atlas Trials

To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

Clinical trial NCT02549430 · COMPLETED

Trial details

NCT number
NCT02549430
Sponsor
Fondazione Sandro Pitigliani
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-10-01
Primary completion
2017-02-09
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.